Background: It has been well documented that human adenovirus type 36 (Ad-36) is associated with obesity. However, the underlying molecular mechanism of Ad-36 inducing obesity remains unknown. We sought to investigate the effect of Ad-36 infection on Cidec, AMPK pathway and lipid metabolism in primary cultured human skeletal muscle cells. Methods: Cidec/fat-specific protein 27 (FSP27), fatty acid oxidation, AMPK signaling and the abundance of proteins involved in lipid synthesis were determined in muscle cells infected with various doses (1.9-7.6 MOI) of Ad-36 and non-lipogenic adenovirus type 2 (Ad-2) as a negative control as well as an uninfected control. Cidec/FSP27 siRNA transfection was performed in Ad-36-infected muscle cells. Results: Our data show that Ad-36 significantly reduced fatty acid oxidation in a dose-dependent manner (all P values are o0.01), but Ad-2 did not affect fatty acid oxidation. Ad-36 substantially increased Cidec/FSP27, ACC, sterol regulatory element-binding protein 1c (SREBP-1c), SREBP-2 and 3-hydroxy-3-methylglutaryl-CoA reductase protein abundance, but significantly reduced AMPK activity, mitochondrial mass and uncoupling protein 3 (UCP3) abundance in comparison with control cells (all P values are o0.01). Oil Red O staining revealed that there was substantial fat accumulation in the Ad-36-infected muscle cells. Furthermore, Cidec/FSP27 siRNA transfection significantly reduced FSP27 expression and partially restored AMPK signaling, increased UCP3 and decreased SERBP 1c and perilipin proteins in Ad-36-infected muscle cells. Interestingly, neither Ad-36 nor Ad-2 affected peroxisome proliferator-activated receptor g protein expression in muscle cells. Conclusion: This study suggests that Ad-36 induced lipid droplets in the cultured skeletal muscle cells and this process may be mediated by promoting Cidec/FSP27 expression.
Introduction
Obesity has become the most prevalent chronic disorder that affects large populations throughout the world. Viral infections have been recognized as a possible cause of obesity, alongside the traditionally recognized causes that include genetic inheritance, and behavior/environmental causes such as diet, exercise, cultural practices and stress. 1 Human adenovirus type 36 (Ad-36) is one of the 50 types of adenoviruses known to infect humans. It has recently been the focus of intense research due to a significant association with obesity. 2 Ad-36 is capable of inducing adiposity in experimentally infected chickens, mice and non-human primates (marmosets). 3 Ad-36 has also been reported to increase replication, differentiation, lipid accumulation and insulin sensitivity in fat cells and to reduce those cells' leptin secretion and expression as well as enhance differentiation of preadipocytes. 4 The presence of Ad-36 antibodies in humans is associated with increased body mass index. 5, 6 In contrast to the conventional association of obesity with insulin resistance, Ad-36-induced obesity appears to decrease plasma glucose, cholesterol, triglyceride and leptin as well as increase adiponectin concentrations. 7 However, the precise mechanism of Ad-36 inducing obesity is largely unknown. Obesity is largely due to the imbalance between energy intake and expenditure. It is believed to be a fat storage disease characterized by insulin resistance and a decreased capacity to oxidize lipids. 8 Energy balance is regulated by interaction between various tissues such as adipose tissue, liver and skeletal muscle. Skeletal muscle is a major target of insulin action, and insulin-stimulated glucose uptake as well as fatty acid oxidation. Therefore, skeletal muscle plays a key role in determining nutrient oxidation rates and is the major site of glucose disposal and insulin action. 9 The increased deposition of intramyocellular triacylglycerols (imTAGs) has received special interest, because several studies have shown a positive association between insulin resistance and imTAG storage. 10 Accumulation of imTAG depends on the availability and uptake of fatty acids, the rate of fatty acid oxidation and the rate of synthesis and hydrolysis of TAG. Increased availability of plasma free fatty acid during lipid infusion or high-fat feeding is associated with development of insulin resistance and accumulation of imTAG in vivo.
11
Recently identified as a set of novel proteins, cell deathinducing DNA fragmentation factor alpha-like effector A (Cidea) and fat-specific protein 27 (FSP27, also known as Cidec), which are associated with lipid droplets in adipocytes and their expression, can enhance the accumulation of triglycerides in adipocytes both in vivo and in vitro. [12] [13] [14] Strikingly, Cidea and FSP27 expression was higher in insulin sensitive vs resistant obese humans. These studies indicate that Cidea and FSP27 define a novel, highly regulated pathway of triglyceride accumulation in mouse and human white adipose tissue and their expression is associated with insulin sensitivity in humans. [15] [16] [17] Perilipin is a protein that coats lipid droplets in adipocytes, the fat-storing cells in adipose tissue. Perilipin behaves as a protective coating from the body's natural lipases, such as hormone-sensitive lipase, which breaks down triglycerides into glycerol and free fatty acids for use in metabolism, a process called lipolysis. 18 Knockdown of FSP27 in 3T3-L1 adipocytes was reported to result in the fragmentation of large lipid droplets to produce many small lipid droplets. Ectopic expression of FSP27 promoted lipid droplet formation when assessed in 3T3-L1 preadipocytes, COS cells and CHO cells. 19 Similar to perilipin, Cidea and the related lipid droplet protein Cidec/FSP27, are controlled by peroxisome proliferator-activated receptor g (PPARg). 20 However, regulation of endogenous Cidec/FSP27, perilipin and PPARg expression in Ad-36-infected muscle cells is still unknown. In a previous study, we reported that Ad-36 results in E4 orf1 virus gene expression, increases glucose uptake and GLUT4 protein abundance independent of insulin signaling in human skeletal muscle cells. 21 Currently, no data are available about the effect of Ad-36 on lipid metabolism and its related cellular signaling such as AMPK pathway, perilipin and Cidec/FSP27 in primary skeletal muscle cell culture. 
Confocal microscopy
Immunofluorescence for Cidec/FSP27 and perilipin were performed on muscle cells at day 6 after infection (Ad-2 or Ad-36 at dose of 3.8 MOI) and uninfected control cells. Briefly, cells growing on glass cover slips were fixed in icecold 2% paraformaldehyde on ice, followed by 10 min of permeabilization in 0.2% Triton X-100 in phosphatebuffered saline (PBS). Reactions were blocked for 30 min with 0.2% BSA, followed by 60 min of incubation with a rabbit polyclonal anti-FSP27 (1:500 dilution) and perilipin antibody (1:500 dilution), FITC-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology) or Alexa Fluor 594-conjugated goat anti-mouse IgG (1:500 dilution; Invitrogen) were added for 30 min (1:500 dilution; Molecular Probes, Invitrogen (Eugene, OR, USA)). Imaging was performed using a Nikon Eclipse TS100 inverted microscope with Nikon digital camera (model DXM1200F) and ACT-1 version 2 software (Melville, NY, USA).
Mitochondrial mass assay
For quantification of mitochondrial content in the virusinfected cells, we used MitoTracker Green probe (Molecular Probes) described by Pendergrass et al. 23 MitoTracker Green probe preferentially accumulates in mitochondria and provides an accurate assessment of mitochondrial mass. Cells were washed with PBS and incubated at 37 1C for 30 min with 40 nM MitoTracker Green FM (Molecular Probes). Cells were harvested using trypsin/EDTA and resuspended in PBS. The relative fluorescence intensity was detected with excitation and emission wavelengths of 490 and 516 nm using a fluorescence microplate spectrophotometer (Biotex, Winooski, VT, USA) and values corrected for total protein (mg ml
À1
).
Fatty acid oxidation assay
Fatty acid oxidation was measured as described by Hulver et al. 24 In brief, at day 6 after infection, muscle cells were incubated in a bicarbonate-buffered Krebs-Ringer medium containing 5 mM glucose, 0.5 mM palmitate, 2% BSA and 0.5 mCi of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C] palmitate. After 3 h, we added 0.5 ml of NaOH to the center of 0.5 tube in the incubation well (to trap CO 2 ), and terminated cellular reactions by addition of 0.5 ml of 1 N H 3 SO 4 to the media. CO 2 was collected for 30 min. Acid-soluble products (ASM) were extracted from the media with chloroform/methanol/NaCl. Incorporation of radioactivity into CO 2 , ASM and total lipids was measured using a liquid-scintillation spectrometer. Portions of cell lysates were used for measuring protein concentration, and results were expressed relative to nmol mg À1 protein per h.
All assays were performed in triplicate.
AMPK activity assay AMPK activity assays were carried out according to Carling's method. 25 In (Figure 3 ).
Ad-36 reduced fatty acid oxidation in muscle cells by altering AMPK signaling, but not PPARg signaling Fatty acid oxidation data reveal that Ad-36 significantly decreased fatty acid oxidation from 100 ± 7%, 62 ± 9%, 56±11% and 43±5% when compared to control when evaluating, 1.9, 3.8, 7.6 doses of Ad-36, respectively (Po0.01 and Po0.001, Figure 4 ). However, Ad-2 did not significantly affect fatty acid oxidation when compared with control (P ¼ NS). AMPK activity and AMPK protein abundances were measured in the muscle cells infected by Ad-2 or Ad-36 viruses. AMPK activities were significantly lower in Ad-36-infected cells than in uninfected control cells in both basal and AMP-stimulated conditions (Po0.05, Po0.01 and Po0.001, respectively in Figure 5a ). Western blotting analysis revealed that phosphorylation of AMPK and AMPK a isoform protein abundance were reduced when compared with control cells. However, there was no significant difference of AMPK-p and AMPK a protein abundance between Ad-2 and control cells (Figure 5b) . Interestingly, neither Ad-36 nor Ad-2 alters PPARg protein expression (Figure 5c ).
Effect of Ad-36 on mitochondrial mass and UCP3 protein abundance in the muscle cells We further measured mitochondrial mass and UCP3 protein abundance in the muscle cells and noted that Ad-36 substantially reduced mitochondrial mass in a dose-dependent manner, but Ad-2 slightly decreased mitochondrial mass in comparison with control cells (Figure 6a ). In addition, Ad-36 significantly reduced UCP3 abundance as well (Figure 6b ). ]-labeled palmitate in a 24-well plate for 3 h as described in the Methods section. Cells were incubated in oxidation media containing 14 C labeled. The assay was carried out in triplicate and the data represent three independent experiments. **Po0.01 and ***Po0.001, virus infected vs control.
Ad-36 promotes Cidec/FSP27 expression ZQ Wang et al protein expression around lipid droplets in the muscle cells, but Ad-2 did not alter these protein levels when compared with control cells (Figures 8a-c) . Oil Red O staining showed Ad-36-induced lipid accumulation in the cells and there were no lipid droplets deposited in the control and Ad-2 infected muscle cells (Figure 8d) . Moreover, Cidec/FSP27 siRNA transfection greatly reduced Cidec/FSp27 and perilipin contents as well as lipid droplets in Ad-36-infected muscle cells.
Discussion
The data demonstrate that Ad-36 increased Cidec/FSP27, perilipin, SERBP 1c, SERBP2, HMGR and ACC protein abundance, and greatly reduced mitochondrial mass and UCP3 protein expression in primary skeletal muscle culture. Furthermore, Ad-36 substantially reduced fatty acid oxidation and decreased AMPK activity, but Ad-2 did not have these effects in the primary human skeletal muscle culture when compared with control culture. Thus, accumulation of fat in Ad-36-infected muscle cells may be associated with reprogramming cellular signaling and significantly elevating Cidec/FSP27 protein, which resulted in inhibition of fatty acid oxidation and increase of de novo lipogenesis.
AMPK is activated by external metabolic stresses and subsequently orchestrates a complex downstream signaling cascade that mobilizes the cell for efficient energy production. AMPK has emerged as a key kinase driving lipid Ad-36 promotes Cidec/FSP27 expression ZQ Wang et al of 3T3-L1 cells substantially decreases lipid droplet size, increases mitochondrial and lipid droplet number and modestly increases glucose uptake and lipolysis. 19, 29 Similar to these findings, localization of Cidec/FSP27 and perilipin to lipid droplets in the Ad-36-infected muscle cells indicates Ad-36 has a key role in the pattern of lipid droplet accumulation in human muscle cells. Ad-36 dramatically reduced muscle mitochondrial mass and UCP3 protein abundance. These effects could contribute to lowering of fatty acid oxidation in the muscle cells because fatty acid oxidation occurs in the mitochondria and UCP3 is a mitochondrial anion carrier protein with highly selective expression in skeletal muscle. Experimental evidence showed increases in muscle levels of UCP3 in a wide variety of in vitro and in vivo experimental systems are consistent with decreased reactive oxygen species production, increased fatty acid oxidation, reduction of intramuscular triglyceride and lipid derivatives. UCP3 action in skeletal muscle may enhance cellular health and longevity, metabolic flexibility and insulin sensitivity. 29 We showed that knockdown of Cidec/FSP27 using Cidec/FSP27 siRNA could partially restore AMPK signaling and increase UCP3 protein abundance in the Ad-36-infected muscle cells. It is well documented that the PPARg regulates expression of adipocyte-specific genes Cidec/FSP27 and perilipin, which results in the promotion of intracellular fat storage. 20 However, we showed neither Ad-36 nor Ad-2 alters PPARg protein abundance in muscle cells (Figure 5c 32, 33 SREBP-1 may be selectively involved in the activation of genes associated with fatty acid metabolism, whereas SREBP-2 is more specific in cholesterol homeostasis, primarily because of its selective activation of the squalene synthase gene. 34 It was reported that glucose upregulated SREBP-1c precursor and nuclear proteins, and the knockdown of SREBP-1 mRNA using an RNA interference technique, totally abrogated the glucose-induced upregulation of lipogenic enzymes. This evidence indicates that SREBP-1c increased intramuscular lipid accumulation associated with muscle insulin resistance in obesity or type 2 diabetes could arise partly from de novo fatty acid synthesis in skeletal muscle. 35 In the cholesterol biosynthetic pathway, the SREBPs directly activate transcription of the genes encoding 3-hydroxy-3-methylglutaryl (HMG) coenzyme A synthase, HMGR, farnesyl diphosphate synthase and squalene synthase. 36, 37 It was well established that activation of AMPK suppresses hepatic SREBP-1 mRNA and nuclear SREBP-1 protein. 38 We observed that Ad-36 significantly increased HMGR abundance in the muscle. AMPK increases lipolysis and reduces lipid synthesis by decreasing SREBPs expression, inhibiting ACC and HMGR activities. Knockdown of FSP27 with siRNA technique increased AMPK phosphorylation and UCP3 content as well as decreased perilipin and SREBP-1c protein abundance in Ad-36-infected muscle cells (Figure 8 ). Therefore, increasing SREBPs, ACC and HMGR expression by AD-36 may result from decreased AMPK activity mediated by elevated Cidec/FSP27 expression. However, Ad-36 does not affect PPARg signaling pathway in muscle cells.
Conclusion
Our study suggests that the dual effects of Ad-36 on lipid metabolism by reducing fatty acid oxidation and increasing de novo lipogenesis, result in fat accumulation in muscle cells that may be modulated by promoting Cidec/FSP27 expression.
